Valeur20202021202220232024TTMFrais de vente, généraux et administratifs10.15 B10.29 B10.41 B10.74 B10.85 B11.45 BRecherche et développement2.49 B2.75 B2.7 B2.73 B2.73 B2.89 BRésultat d'exploitation4.48 B5.75 B5.49 B5.14 B5.96 B6.03 BTotal des produits hors exploitation337 M368 M450 M410 M408 M162 MCharges d'intérêts, nettes des intérêts capitalisés925 M553 M636 M719 M1.64 B1.59 BRésultat hors exploitation, hors charges d'intérêts-924 M-503 M-701 M-721 M-1.64 B-1.68 BRevenus/dépenses exceptionnels336 M318 M515 M412 M402 M246 MRésultat avant impôts3.9 B5.52 B5.36 B4.84 B5.63 B5.56 BPart des actionnaires dans le résultat——————Impôts265 M456 M1.58 B1.13 B936 M922 MIntérêts ne donnant pas le contrôle / intérêts minoritaires24 M22 M26 M28 M29 M25 MAutres produits/charges après impôts-251 M-138 M-270 M-573 M-310 M-576 MRésultat net avant activités abandonnées3.61 B5.04 B3.76 B3.68 B4.66 B4.61 BActivités abandonnées——————Résultat net3.61 B5.04 B3.76 B3.68 B4.66 B4.61 BAjustement de dilution——————Dividendes privilégiés——————Résultat net dilué revenant aux actionnaires ordinaires3.61 B5.04 B3.76 B3.68 B4.66 B4.61 BBénéfice par action de base (BPA de base)2.683.752.832.773.633.59Bénéfice par action dilué (BPA dilué)2.663.732.822.763.613.58Nombre moyen d'actions de base en circulation1.34 B1.34 B1.33 B1.33 B1.29 B—Nombre d'actions en circulation après dilution1.35 B1.35 B1.33 B1.33 B1.29 B—EBITDA7.78 B8.55 B8.18 B7.46 B8.85 B6.22 BEBIT5.08 B5.84 B5.48 B4.82 B5.99 B4.67 BCoût des ventes10.48 B10.14 B10.72 B11.22 B11.63 B12.47 BAutres coûts des ventes——————Amortissements (flux de trésorerie)2.7 B2.71 B2.7 B2.65 B2.86 B3.08 B
Medtronic plc. Ordinary Shares
Medtronic plc is an American-Irish medical device company. The company's legal and executive headquarters are in Ireland, while its operational headquarters are in Minneapolis, Minnesota. Medtronic rebased to Ireland following its acquisition of Irish-based Covidien in 2015. While it primarily operates in the United States, it operates in more than 150 countries and employs over 90,000 people. It develops and manufactures healthcare technologies and therapies. It is one of the biggest medical tech companies in the world and is currently the largest medical device company in the world by revenue.
The company has developed several world-first technologies since its inception, including wearable and implantable pacemakers, the implantable cardioverter-defibrillator, and remote patient monitoring systems. They also created miniaturized devices like the world's smallest pacemaker and spinal cord stimulator.